Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil G Berry

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2011
Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patientsXiaoli Meng, Rosalind E Jenkins, Neil G Berry, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2011
Carbon monoxide poisoning is prevented by the energy costs of conformational changes in gas-binding haemproteinsSvetlana V Antonyuk, Neil Rustage, Christine A Petersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2015
Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1Michael J Capper, Paul M O'Neill, Nicholas Fisher, et al.
Frontiers in Pharmacology|January 26, 2024
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitorsRachel H Clare, Charlotte A Dawson, Adam Westhorpe, et al.
Science Advances|September 30, 2017
Identification and prioritization of novel anti-<i>Wolbachia</i> chemotypes from screening a 10,000-compound diversity libraryKelly L Johnston, Darren A N Cook, Neil G Berry, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Antimalarial 2-Pyrazolyl Quinolone <i>bc</i> <sub>1</sub> (Q<sub>i</sub>) Inhibitors with Improved Drug-like PropertiesW David Hong, Suet C Leung, Kangsa Amporndanai, et al.
Journal of Medicinal Chemistry|February 25, 2016
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction SitesMichael H L Wong, Holly K Bryan, Ian M Copple, et al.
Biology|July 27, 2022
Targeting the Ubiquinol-Reduction (Q<sub>i</sub>) Site of the Mitochondrial Cytochrome <i>bc<sub>1</sub></i> Complex for the Development of Next Generation Quinolone AntimalarialsKangsa Amporndanai, Nattapon Pinthong, Paul M O'Neill, et al.
ACS Infectious Diseases|January 20, 2016
<i>Plasmodium</i> IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial TargetLeah S Imlay, Christopher M Armstrong, Mary Clare Masters, et al.
Journal of Medicinal Chemistry|May 11, 2011
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replicationAndrew V Stachulski, Chandrakala Pidathala, Eleanor C Row, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2011
Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patientsXiaoli Meng, Rosalind E Jenkins, Neil G Berry, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2011
Carbon monoxide poisoning is prevented by the energy costs of conformational changes in gas-binding haemproteinsSvetlana V Antonyuk, Neil Rustage, Christine A Petersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2015
Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1Michael J Capper, Paul M O'Neill, Nicholas Fisher, et al.
Frontiers in Pharmacology|January 26, 2024
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitorsRachel H Clare, Charlotte A Dawson, Adam Westhorpe, et al.
Science Advances|September 30, 2017
Identification and prioritization of novel anti-<i>Wolbachia</i> chemotypes from screening a 10,000-compound diversity libraryKelly L Johnston, Darren A N Cook, Neil G Berry, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Potent Antimalarial 2-Pyrazolyl Quinolone <i>bc</i> <sub>1</sub> (Q<sub>i</sub>) Inhibitors with Improved Drug-like PropertiesW David Hong, Suet C Leung, Kangsa Amporndanai, et al.
Journal of Medicinal Chemistry|February 25, 2016
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction SitesMichael H L Wong, Holly K Bryan, Ian M Copple, et al.
Biology|July 27, 2022
Targeting the Ubiquinol-Reduction (Q<sub>i</sub>) Site of the Mitochondrial Cytochrome <i>bc<sub>1</sub></i> Complex for the Development of Next Generation Quinolone AntimalarialsKangsa Amporndanai, Nattapon Pinthong, Paul M O'Neill, et al.
ACS Infectious Diseases|January 20, 2016
<i>Plasmodium</i> IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial TargetLeah S Imlay, Christopher M Armstrong, Mary Clare Masters, et al.
Journal of Medicinal Chemistry|May 11, 2011
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replicationAndrew V Stachulski, Chandrakala Pidathala, Eleanor C Row, et al.
Pageof 7